Clinical Trial Update: A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia [Phase 3]

View source ↗

Summary

Phase 3 long-term study evaluating safety and efficacy of dutasteride in men with androgenetic alopecia has completed. Results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• DUTASTERIDE (Dutasteride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Alopecia | Phase 3 | Status: COMPLETED | Results posted: 2015-03-12